Clinical Trials Logo

ATM Gene Mutation clinical trials

View clinical trials related to ATM Gene Mutation.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03962114 Completed - Clinical trials for Ataxia Telangiectasia

Effects of Vitamin B3 in Patients With Ataxia Telangiectasia

Start date: March 18, 2019
Phase: Phase 2
Study type: Interventional

This clinical trial investigates the effects of nicotinamide riboside (vitamin B3) on the disease course of patients with ataxia telangiectasia. Patients will be treated during four consecutive months with nicotinamide riboside (25mg/kg/day), followed by a washout period of two months. Main study parameters/endpoints: Ataxia, dysarthria, quality of life, laboratory parameters.

NCT ID: NCT03377556 Completed - BRCA1 Gene Mutation Clinical Trials

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

Start date: March 3, 2017
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well talazoparib works in treating patients with homologous recombination repair deficiency (HRRD) positive stage IV squamous cell lung cancer that has come back after previous treatment. Talazoparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.